ArticleJournal of multidisciplinary healthcare2026
The Relationship Between Symptom Burden and Death Anxiety in Ovarian Cancer Patients: The Mediating Effect of Alexithymia.
Article in Journal of multidisciplinary healthcare, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development and Validation of a Multi-Omics Model Integrating US-Derived and WSI-Based Features to Predict Lymph Node Metastasis in Ovarian Cancer: A Multi-Center Retrospective Study.International journal of women's health · 2026Article
- Sleep disturbance, anxiety, and depression in postoperative ovarian cancer patients: prevalence, associated factors, and symptom interrelationships.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to reveal the relationship between death anxiety, symptom burden and alexithymia in ovarian cancer patients, and to explore the potential mediating role of alexithymia in the relationship between symptom burden and death anxiety. Patients and Methods: 247 patients with ovarian cancer in five tertiary hospitals in Sichuan, China were investigated by convenient sampling method from March 2024 to March 2025. Participants completed demographic questionnaires, the MD Anderson Symptom Inventory, the Toronto Alexithymia Scale, and the Templer-Death Anxiety Scale. SPSS 27.0 software was used for Pearson correlation analysis and analysis of variance, and mediation analysis was conducted with Model 4 in the Process v4.2. Results: Most patients were aged 45 years or older, had a senior high school education or below, were married, had medical insurance under the New Rural Cooperative Medical Scheme or Resident Basic Medical Insurance, and had a household income between 5000 and 10,000 yuan. The score of the Templer-Death Anxiety scale for ovarian cancer patients was (46.38 ± 6.92), which was at a high level. Statistically Significant differences were observed in death anxiety scores among patients of different ages, educational levels, tumor stages, disease duration, and marital status. Correlation analysis revealed significant correlations among symptom burden, alexithymia, and death anxiety. Symptom burden had a significant positive influence on alexithymia and death anxiety. Additionally, alexithymia had a significant positive impact on death anxiety. Mediation analysis revealed that alexithymia partially mediated the relationship between symptom burden and death anxiety. Conclusion: We should focus on patients who are younger, unmarried or divorced/widowed, have lower educational attainment, are at a later stage of tumor progression, and have a shorter disease course. Symptom burden influences death anxiety in ovarian cancer patients by affecting alexithymia. Focusing solely on symptom burden without addressing patients' alexithymia may not be sufficient to reduce their death anxiety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.